DCN and cancer: The interaction of decorin with TGF-β causes strong inhibition of proliferation in various cancer cell lines, presumably by decorin-binding activity on TGF-β isoform 1 (TGF-β1), thereby sequestrating it in the ECM and limiting its bioactivity (117).